prednisolon
PreclinicalSmall molecule
prednisolon is one of 7 small molecule programs targeting Heart Transplantation. It is currently in Preclinical.
1
Indications
4
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Heart Transplantation
#DrugCompanyPhaseTrials
1Cellcept
RochePhase 2
Nulojix
Bristol-Myers SquibbPhase 2
Prograf
VVeloxis Pharmaceuticals
Phase 2
Custodiol-N
DDr. F. Köhler Chemie GmbH
Phase 3
Cyclosporin a
NovartisPreclinical
Mycophenolatmofetile
HHannover Medical School
Preclinical
prednisolon
EErasmus Medical Center
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Crohn's Disease1 trial
Heart Transplantation1 trial
IgA Nephropathy1 trial
Efficacy and Safety of Mycophenolate Mofetil in Patients With Refractory IgA Nephropathy in Bangladesh: A Phase II Randomized Controlled Trial
Not yet recruiting·SShaheed Suhrawardy Medical College and Hospital·Phase 2·NCT07785128·104 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for prednisolon. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- EErasmus Medical Center